Why Repros Therapeutics Inc (RPRX) Was One Of Black Friday’s Biggest Gainers

Seeing as Repros Therapeutics Inc (NASDAQ:RPRX) has experienced a declination in interest from hedge fund managers, it’s easy to see that there were a few fund managers that decided to sell off their entire stakes in the third quarter. It’s worth mentioning that Cliff Asness’ AQR Capital Management said goodbye to the biggest stake of the 700 funds followed by Insider Monkey, totaling close to $0.3 million in stock, and Chao Ku’s Nine Chapters Capital Management was right behind this move, as the fund sold off about $0.3 million worth of shares as well. These moves are interesting, as total hedge fund interest dropped by two funds in the third quarter.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Repros Therapeutics Inc (NASDAQ:RPRX) but similarly valued. These stocks are SeaSpine Holdings Corp (NASDAQ:SPNE), Avinger Inc (NASDAQ:AVGR), Quinpario Acquisition Corp 2 (NASDAQ:QPACU), and VOXX International Corp (NASDAQ:VOXX). This group of stocks’ market caps are closest to Repros Therapeutics Inc (NASDAQ:RPRX)’s market cap.

As you can see these stocks had an average of 10.25 hedge funds with bullish positions and the average amount invested in these stocks was $64 million. That figure was $44 million in Repros Therapeutics Inc (NASDAQ:RPRX)’s case. Quinpario Acquisition Corp 2 (NASDAQ:QPACU) is the most popular stock in this table. On the other hand Avinger Inc (NASDAQ:AVGR) is the least popular one with only 5 bullish hedge fund positions. Compared to these stocks Repros Therapeutics Inc (NASDAQ:RPRX) is more popular among hedge funds, although the amount of money invested in it is only average. Considering that hedge funds are generally fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio before or after Monday’s announcement.